A nucleoside- and ritonavir-sparing regimen containing atazanavir plus raltegravir in antiretroviral treatment-naïve HIV-infected patients: SPARTAN study results.
Kozal MJ, Lupo S, DeJesus E, Molina JM, McDonald C, Raffi F, Benetucci J, Mancini M, Yang R, Wirtz V, Percival L, Zhang J, Zhu L, Arikan D, Farajallah A, Nguyen BY, Leavitt R, McGrath D, Lataillade M, The Spartan Study Team.
Kozal MJ, et al. Among authors: zhu l.
HIV Clin Trials. 2012 May-Jun;13(3):119-30. doi: 10.1310/hct1303-119.
HIV Clin Trials. 2012.
PMID: 22592092
Clinical Trial.